ATE479432T1 - Verfahren zur verabreichung einer antitumoralen verbindung - Google Patents

Verfahren zur verabreichung einer antitumoralen verbindung

Info

Publication number
ATE479432T1
ATE479432T1 AT07821854T AT07821854T ATE479432T1 AT E479432 T1 ATE479432 T1 AT E479432T1 AT 07821854 T AT07821854 T AT 07821854T AT 07821854 T AT07821854 T AT 07821854T AT E479432 T1 ATE479432 T1 AT E479432T1
Authority
AT
Austria
Prior art keywords
administration
antitumoral compound
antitumoral
compound
Prior art date
Application number
AT07821854T
Other languages
English (en)
Inventor
Bernard Laffranchi
Jurgen Moll
Fabrina Bologna
Silvia Comis
Original Assignee
Nerviano Medical Sciences Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nerviano Medical Sciences Srl filed Critical Nerviano Medical Sciences Srl
Application granted granted Critical
Publication of ATE479432T1 publication Critical patent/ATE479432T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/41621,2-Diazoles condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT07821854T 2006-11-03 2007-10-25 Verfahren zur verabreichung einer antitumoralen verbindung ATE479432T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06123440 2006-11-03
PCT/EP2007/061491 WO2008052931A1 (en) 2006-11-03 2007-10-25 A method of administering an antitumor compound

Publications (1)

Publication Number Publication Date
ATE479432T1 true ATE479432T1 (de) 2010-09-15

Family

ID=38702074

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07821854T ATE479432T1 (de) 2006-11-03 2007-10-25 Verfahren zur verabreichung einer antitumoralen verbindung

Country Status (16)

Country Link
US (1) US20100256160A1 (de)
EP (1) EP2117539B1 (de)
JP (1) JP5547487B2 (de)
CN (1) CN101588800B (de)
AR (1) AR063459A1 (de)
AT (1) ATE479432T1 (de)
AU (1) AU2007316217A1 (de)
BR (1) BRPI0717998A2 (de)
CA (1) CA2668363A1 (de)
CL (1) CL2007003172A1 (de)
DE (1) DE602007008949D1 (de)
EA (1) EA200970444A1 (de)
ES (1) ES2350803T3 (de)
MX (1) MX2009004607A (de)
TW (1) TW200827361A (de)
WO (1) WO2008052931A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5518062B2 (ja) * 2008-07-24 2014-06-11 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ オーロラキナーゼ阻害剤および抗悪性腫瘍剤を含む治療用組み合わせ
WO2010009985A2 (en) 2008-07-24 2010-01-28 Nerviano Medical Sciences S.R.L. Therapeutic combination comprising an aurora kinase inhibitor and antiproliferative agents
CN105037399B (zh) * 2014-04-17 2017-04-26 深圳永泽医药股份有限公司 一类Bcr‑Abl双倍体抑制剂及制备方法与用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ302498B6 (cs) * 1999-11-15 2011-06-15 Pharma Mar, S. A. Farmaceutický prípravek obsahující aplidin pro lécení rakovinových onemocnení
WO2003024926A2 (en) * 2001-09-21 2003-03-27 Reddy Us Therapeutics, Inc. Methods and compositions of novel triazine compounds
US7141568B2 (en) * 2003-07-09 2006-11-28 Pfizer Italia S.R.L. Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
NZ549605A (en) * 2004-02-06 2010-01-29 Threshold Pharmaceuticals Inc Use of glufosfamide to treat chemotherapy-refractory pancreatic cancer
TW200808311A (en) * 2006-03-30 2008-02-16 Nerviano Medical Sciences Srl Use of a kinase inhibitor for the treatment of particular resistant tumors

Also Published As

Publication number Publication date
MX2009004607A (es) 2009-05-22
CN101588800B (zh) 2012-01-04
JP2010523470A (ja) 2010-07-15
US20100256160A1 (en) 2010-10-07
CL2007003172A1 (es) 2008-06-27
JP5547487B2 (ja) 2014-07-16
AR063459A1 (es) 2009-01-28
TW200827361A (en) 2008-07-01
CA2668363A1 (en) 2008-05-08
EA200970444A1 (ru) 2009-12-30
EP2117539A1 (de) 2009-11-18
BRPI0717998A2 (pt) 2013-12-03
ES2350803T3 (es) 2011-01-27
AU2007316217A1 (en) 2008-05-08
EP2117539B1 (de) 2010-09-01
DE602007008949D1 (de) 2010-10-14
WO2008052931A1 (en) 2008-05-08
CN101588800A (zh) 2009-11-25

Similar Documents

Publication Publication Date Title
ATE455105T1 (de) Verfahren zur herstellung von difluormethylpyrazolylcarboxylaten
DE602007003705D1 (de) Verfahren zur Steuerung der Verbindung eines virtuellen Netzwerkes
ATE533747T1 (de) Verfahren zur herstellung von tetrahydrochinolinderivaten
ATE538111T1 (de) Verfahren zur synthese von 5- alkoxymethylfurfuralethern
EP2217259A4 (de) Verfahren zur behandlung von erkrankungen mit mangel an thiolhaltiger verbindung
DE602008006478D1 (de) Eindickungszusammensetzung und Verfahren zur Eindickung wässriger Systeme
EP2170785A4 (de) Verfahren zur herstellung von hydrofluorolefinen
DE602007007400D1 (de) Verfahren zur Niveauregulierung
DE502007003700D1 (de) Verfahren zur Herstellung von Glycerin
ATE480531T1 (de) Verfahren zur herstellung von benzopyran-2- olderivaten
EP2060349A4 (de) Verfahren zur herstellung eines durchgangslochs
DE602004024318D1 (de) Verfahren zur Erstellung einer Audiosignatur
DE602006020089D1 (de) Verfahren zur CVI
DE602008004919D1 (de) Eindickungsmischungszusammensetzung und Verfahren zur Eindickung wässriger Systeme
DE602007003135D1 (de) Verfahren zur Herstellung von Xylylenediamin
DE502007000875D1 (de) Verfahren zur Herstellung von ß-Ketocarbonyl-funktionellen Organosiliciumverbindungen
DE602007002359D1 (de) Verfahren zur Wiederherstellung einer Video-auf-Anfrage Sitzung
DE502007000339D1 (de) Verfahren zur Herstellung von Urethangruppen aufweisenden Organosiliciumverbindungen
DE602007007224D1 (de) Verfahren zur Gewebebewahrung
ATE544755T1 (de) Verfahren zur herstellung einer 5-alkoxy-4- hydroxymethylpyrazolverbindung
DE602007009482D1 (de) Verfahren zur elektroleitfähigen schaltungsbildung
DE112007001447A5 (de) Verfahren zur Abstandsregelung
DE602007007767D1 (de) Verfahren zur verbindung zweier röhrenenden
ATE479432T1 (de) Verfahren zur verabreichung einer antitumoralen verbindung
EP2208708A4 (de) Verfahren zur herstellung einer alkalititanatverbindung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2117539

Country of ref document: EP